Trial · NCT00413699
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Period | STARTED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 1,123 | |
| Initial Period | STARTED | Initial Period: Tofacitinib 10 mg BID | 3,358 | |
| Initial Period | STARTED | Extension Period: Tofacitinib 5 mg | 0 | |
| Initial Period | COMPLETED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 484 | |
| Initial Period | COMPLETED | Initial Period: Tofacitinib 10 mg BID | 1,653 | |
| Initial Period | COMPLETED | Extension Period: Tofacitinib 5 mg | 0 | |
| Initial Period | NOT COMPLETED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 639 | |
| Initial Period | NOT COMPLETED | Initial Period: Tofacitinib 10 mg BID | 1,705 | |
| Initial Period | NOT COMPLETED | Extension Period: Tofacitinib 5 mg | 0 | |
| Extension Period | STARTED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 0 | |
| Extension Period | STARTED | Initial Period: Tofacitinib 10 mg BID | 0 | |
| Extension Period | STARTED | Extension Period: Tofacitinib 5 mg | 48 | |
| Extension Period | COMPLETED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 0 | |
| Extension Period | COMPLETED | Initial Period: Tofacitinib 10 mg BID | 0 | |
| Extension Period | COMPLETED | Extension Period: Tofacitinib 5 mg | 43 | |
| Extension Period | NOT COMPLETED | Initial Period: Tofacitinib 5 Milligram(mg) Twice Daily (BID) | 0 | |
| Extension Period | NOT COMPLETED | Initial Period: Tofacitinib 10 mg BID | 0 | |
| Extension Period | NOT COMPLETED | Extension Period: Tofacitinib 5 mg | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00413699/flow